Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
METTL15 is an N4-methylcytidine (m^4^C) methyltransferase responsible for the methylation of position C839 in mitochondrial 12S rRNA. It plays a crucial role in mitochondrial ribosome assembly and translation, affecting oxidative phosphorylation performance. Despite its methyltransferase activity, METTL15 primarily functions as an assembly factor, guiding the biogenesis of the mitochondrial small subunit ribosome. While METTL15's catalytic activity is not essential for its role in mitoribosome biogenesis, its presence is crucial for mitochondrial function. The enzyme is structurally related to bacterial RsmH and interacts with mitochondrial ribosome-binding factor RBFA, facilitating a conformational change necessary for ribosome assembly.
Modulation of mitochondrial translation and ribosome assembly
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 12S rRNA N(4)-cytidine methyltransferase (METTL15).